Patrick Holmes, Senior Director, Innovation Policy Lead, heads a team with responsibility for developing global health policy initiatives and evidence across a series of policy issues in support of Pfizer’s R&D-driven business model. These global initiatives are designed to drive positive impact with a focus on market-based R&D incentives, ensuring strong R&D ecosystems, value and innovation frameworks, sustainable patient-centric health systems, and antimicrobial resistance. Patrick represents Pfizer on several health and biopharma working groups, including the Business @ OECD Health Committee, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Value and Access Committee, and the European Federation of Pharmaceutical Industries and Associations (EFPIA) Healthcare Systems Working Group.
Patrick brings a range of experiences to his current role having worked across multiple areas of the biopharmaceutical business during his nearly 30-year career at Pfizer. Patrick joined Pfizer as a marketing associate in 1990 and held multiple positions of increasing responsibility in both US and global marketing spanning a range of therapeutic areas including hypertension, lipid lowering, arrhythmia, diabetes, erectile dysfunction, and allergies. Patrick then switched to a strategic planning role where he was responsible for evaluating new product opportunities and providing strategic input on behalf of the US commercial organization. He then led the Portfolio and Decision Analysis group, supporting strategic decisions and investment tradeoffs across Pfizer’s development portfolio. His last assignment prior to joining the policy team was Vice President, Strategy and Portfolio Support, providing comprehensive insights and identifying key emerging trends for Pfizer leaders.
Patrick has a BA in biology from Middlebury College and an MS in management from the Massachusetts Institute of Technology Sloan School of Management.
Recent Events and Presentations
Lessons Learned From Global Life Sciences Ecosystems in the COVID-19 Pandemic
ITIF hosted a discussion on this critical issue. The event featured a keynote address by Simon Tripp of TEConomy Partners, author of the new report “Response and Resilience: Lessons Learned from Global Life Sciences Ecosystems in the COVID-19 Pandemic,” followed by an expert panel of respondents.